Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.

Miniature organs on a chip could allow us to do scientific studies with great precision, without having to resort to animal testing. The main problem, however, is that artificial tissue needs blood ...

Blood vessels are like big-city highways; full of curves, branches, merges, and congestion. Yet for years, lab models ...

A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has ...

In biomedical research, so-called organs-on-a-chip, also referred to as microphysiological systems, are becoming increasingly ...

Biotech major Biogen (Nasdaq: BIIB) and fellow Cambridge, USA-based City Therapeutics, today announced a strategic ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Biogen Inc. (Nasdaq: BIIB) and City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

Download Free Sample of This Strategic Report with Industry Analysis @ Some key pointers that are often covered in reports on the Vietnam 3D Cell Culture Market . Market Size and Growth: Analysis of ...

UW Medicine advances human tissue modelling with 3D printing. The device is small enough to fit on a fingertip.